Canada Secures Avian Influenza Vaccine Amidst Global H5N1 Concerns

The Public Health Agency of Canada (PHAC) has made a significant move in the fight against avian influenza, securing 500,000 initial doses of GSK’s human vaccine to safeguard people at the highest risk. This proactive measure comes as alerts about the H5N1 strain continue to escalate globally.

Distributing and Stockpiling Vaccine

In a statement, PHAC emphasized that its purchase is based on an existing agreement with GSK. The vaccine, Arepanrix H5N1 A/American wigeon clade 2.3.4.4b, will serve as a critical component of Canada’s contingency plans for individuals at heightened risk of exposure to avian influenza.

Health Canada completed its review of GSK’s regulatory submission on February 18, authorizing the change in vaccine strain. According to PHAC, the risk to the general public remains low. However, 60% of the doses will be distributed to provinces and territories using a risk-based approach, with the remaining 40% stored in Canada’s national stockpile.

Initial Recommendations from Vaccine Advisers

Today, Canada’s National Advisory Committee on Immunization (NACI) issued preliminary guidance on the use of human vaccines against avian flu in nonpandemic settings. While NACI does not recommend a broad deployment of the H5N1 vaccine, it outlines specific high-risk scenarios where its proactive use could be justified, including for laboratory workers and those with ongoing contact with infected animals or contaminated environments.

International preparations for H5N1 include stockpiling vaccines: The US, EU, and UK have taken similar measures. Finland is already vaccinating high-risk individuals, such as those working at fur farms.

Canada, too, has reported multiple H5N1 detections in poultry and wild birds, particularly in British Columbia, where a severe infection in a teenager was reported in November, though the specific source of exposure is still unknown.

First H5N1 Detections in Rats

In a groundbreaking development, tests by the US Department of Agriculture (USDA) have confirmed the H5N1 strain in rats for the first time. Eight mammalian infections were detected, with four in black rats in Riverside County, California, an area that recently experienced poultry outbreaks.

Other mammals found to be infected include a harbor seal in Massachusetts, a fox in North Dakota, a bobcat in Washington state, and a domestic cat in Oregon. The cat’s infection is linked to a recent report of two pets in Multnomah County sickened by raw pet food contaminated with the virus.

While USDA’s records show no new poultry or dairy cattle confirmations since February 14, the agency has reported three additional wild bird confirmations: an agency-harvested raven in California, an agency-harvested duck in New Mexico, and a hunter-harvested duck in Alabama.

Reversing USDA Firings of Avian Flu Response Employees

In a surprising turn of events, the USDA is working to rehire employees who were recently laid off from the bird flu response. According to a statement by a USDA spokesperson, frontline positions in the Food Safety and Inspection Services (FSIS) are deemed public safety positions, and the agency is committed to maintaining its workforce to protect the nation’s food supply.

The spokesperson noted that several positions were already exempt from the cuts, and the USDA continues to prioritize the response to highly pathogenic avian flu.

The Call to Action

The global and national responses to avian influenza highlight the ongoing need for vigilance and preparedness. As the situation evolves, staying informed and adhering to guidelines provided by health authorities is crucial.

We encourage you to share your thoughts and comments below. If you find this information valuable, please consider subscribing to our newsletter to receive the latest updates on health and public safety. Don’t forget to follow us on social media for breaking news and expert insights.